Cambridge Investment Research Advisors, Inc. Trans Medics Group, Inc. Transaction History
Cambridge Investment Research Advisors, Inc.
- $29.4 Billion
- Q3 2024
A detailed history of Cambridge Investment Research Advisors, Inc. transactions in Trans Medics Group, Inc. stock. As of the latest transaction made, Cambridge Investment Research Advisors, Inc. holds 2,604 shares of TMDX stock, worth $179,910. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,604
Previous 2,604
-0.0%
Holding current value
$179,910
Previous $392,000
4.34%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding TMDX
# of Institutions
397Shares Held
31.7MCall Options Held
466KPut Options Held
286K-
Vanguard Group Inc Valley Forge, PA3.6MShares$248 Million0.01% of portfolio
-
Black Rock Inc. New York, NY2.65MShares$183 Million0.01% of portfolio
-
Driehaus Capital Management LLC Chicago, IL1.44MShares$99.6 Million2.22% of portfolio
-
State Street Corp Boston, MA1.27MShares$88 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA1.09MShares$75.6 Million0.03% of portfolio
About TransMedics Group, Inc.
- Ticker TMDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 31,831,400
- Market Cap $2.2B
- Description
- TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and custo...